{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T05:41:47Z","timestamp":1778996507653,"version":"3.51.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Cytokines are an important modulator of the immune system and have been found to be altered significantly in many neurological and psychiatric disorders, like obsessive compulsive disorder (OCD) and movement disorders. Also, in pediatric autoimmune neuropsychiatric disorders associated with group A streptococcal infections (PANDAS), which are characterized by abrupt debut of symptoms of OCD and \/or movement disorder symptoms, alterations in the immune system have been suggested. The aim of this paper was to review the current literature on the cytokine profile of pediatric patients with symptoms of OCD and\/or movement disorder symptoms. A search of PubMed and Medline was performed with specific keywords to review studies measuring cytokines in pediatric patients with symptoms of OCD and\/or movement disorders. Nineteen studies were found, twelve of which included a healthy control group, while four studies had control groups of children with other disorders, primarily neurological or psychiatric. One study compared cytokines measurements to reference intervals, and two studies had a longitudinal design. Many cytokines were found to have significant changes in patients with symptoms of OCD and\/or movement disorders compared to both healthy controls and other control groups. Furthermore, differences were found when comparing cytokines in periods of exacerbation with periods of remission of symptoms in study participants. The cytokines that most studies with healthy control groups found to be significantly altered were TNF-\u03b1, IL-1\u03b2 and IL-17. Although the exact role of these cytokines in OCD and movement disorder symptoms remains unclear, the available literature suggests a proinflammatory cytokine profile. This offers interesting perspectives on the pathogenesis of OCD and\/or movement disorder symptoms in children, and further research into the implications of cytokines in neuropsychiatric disorders is warranted.<\/jats:p>","DOI":"10.3389\/fped.2022.893815","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T07:11:06Z","timestamp":1660893066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Cytokine profile of pediatric patients with obsessive-compulsive and\/or movement disorder symptoms: A review"],"prefix":"10.3389","volume":"10","author":[{"given":"Rebecca Alison","family":"Fabricius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla Birgitte","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liselotte","family":"Skov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanette Mol","family":"Debes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1192\/bjp.bp.111.104471","article-title":"Autoimmunity in psychiatry","volume":"200","author":"Davison","year":"2012","journal-title":"Br J Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1155\/2019\/7403796","article-title":"Regulation of inflammation in autoimmune disease","volume":"28","author":"Duan","year":"2019","journal-title":"J Immunol Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1172\/JCI200114235","article-title":"Mechanisms for the induction of autoimmunity by infectious agents","volume":"108","author":"Wucherpfennig","year":"2001","journal-title":"J Clin Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1089\/cap.2010.0043","article-title":"The immunobiology of tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: a way forward","volume":"20","author":"Murphy","year":"2010","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5334\/tohm.167","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an evolving concept","volume":"25","author":"Macerollo","year":"2013","journal-title":"Tremor Hyperkinetic Mov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1542\/peds.92.1.39","article-title":"Antineuronal antibodies in movement disorders","volume":"92","author":"Kiessling","year":"1993","journal-title":"Pediatrics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00004583-199503000-00015","article-title":"Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and tourette's syndrome","volume":"34","author":"Allen","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","article-title":"Immune modulation of learning, memory, neural plasticity and neurogenesis","volume":"25","author":"Yirmiya","year":"2011","journal-title":"Brain Behav Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/IJICMR.S76710","article-title":"The cytokine profile of OCD: pathophysiological insights","volume":"7","author":"Marazziti","year":"2015","journal-title":"Int J Interferon Cytokine Mediat Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.pnpbp.2010.06.028","article-title":"Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder","volume":"34","author":"Bos-Veneman","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12031-012-9811-8","article-title":"Detection of autoantibodies and increased concentrations of interleukins in plasma from patients with Tourette's syndrome","volume":"48","author":"Cheng","year":"2012","journal-title":"J Mol Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00787-017-1099-3","article-title":"Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive\u2013compulsive disorder","volume":"27","author":"\u00c7olak Sivri","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.pnpbp.2009.05.001","article-title":"A cytokine study in children and adolescents with Tourette's disorder","volume":"33","author":"Gabbay","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.psyneuen.2015.08.017","article-title":"IL-8 and the innate immunity as biomarkers in acute child and adolescent psychopathology","volume":"62","author":"Gariup","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","article-title":"Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome","volume":"57","author":"Leckman","year":"2005","journal-title":"Biol Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00381-015-2692-8","article-title":"Streptococcal infection and immune response in children with Tourette's syndrome","volume":"31","author":"Li","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-244X-12-29","article-title":"Altered monocyte activation markers in Tourette's syndrome: a case\u2013control study","volume":"12","author":"Matz","year":"2012","journal-title":"BMC Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cyto.2017.03.003","article-title":"Case-control, exploratory study of cerebrospinal fluid chemokines\/cytokines and lymphocyte subsets in childhood Tourette syndrome with positive streptococcal markers","volume":"96","author":"Pranzatelli","year":"2017","journal-title":"Cytokine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12974-017-1042-z","article-title":"Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder","volume":"28","author":"Rodr\u00edguez","year":"2017","journal-title":"J Neuroinflammation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"pyw027","DOI":"10.1093\/ijnp\/pyw027","article-title":"Serum cytokine profiles of children with obsessive-compulsive disorder shows the evidence of autoimmunity","volume":"19","author":"Sim\u015fek","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.psychres.2016.11.005","article-title":"A cytokine study of pediatric Tourette's disorder without obsessive compulsive disorder","volume":"247","author":"Yeon","year":"2017","journal-title":"Psychiatry Res"},{"key":"B24","unstructured":"Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease29949\n            MittlemanBB\n            CastellanosFX\n            JacobsenLK\n            RapoportJL\n            SwedoSE\n            ShearerGM\n          9300724J Immunol.1591950"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1229","DOI":"10.1002\/cti2.1229","article-title":"Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disorders","volume":"9","author":"Pilli","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0165-5728(03)00012-2","article-title":"CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome?","volume":"136","author":"Church","year":"2003","journal-title":"J Neuroimmunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/0194599815577784","article-title":"Pediatric autoimmune neuropsychiatric disorder associated with streptococcus immunology: a pilot study","volume":"153","author":"Walls","year":"2015","journal-title":"Otolaryngol Neck Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/cap.2018.0127","article-title":"Establishing a pediatric acute-onset neuropsychiatric syndrome clinic: baseline clinical features of the pediatric acute-onset neuropsychiatric syndrome cohort at karolinska institutet","volume":"29","author":"Gromark","year":"2019","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e9769","DOI":"10.1097\/MD.0000000000009769","article-title":"Association between TNF-\u03b1-238G\/A gene polymorphism and OCD susceptibility","volume":"97","author":"Jiang","year":"2018","journal-title":"Medicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/cap.2014.0103","article-title":"Cytokine correlations in youth with tic disorders","volume":"25","author":"Parker-Athill","year":"2015","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1542\/peds.2007-2658","article-title":"Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"121","author":"Singer","year":"2008","journal-title":"Pediatrics."},{"key":"B32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.comppsych.2013.12.018","article-title":"Neuroinflammation in the fetus exposed to maternal obsessive\u2013compulsive disorder during pregnancy: a comparative study on cord blood tumor necrosis factor-alpha levels","volume":"55","author":"Uguz","year":"2014","journal-title":"Compr Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/S0004-282X2012000200003","article-title":"Association study between functional polymorphisms in the TNF-alpha gene and obsessive-compulsive disorder","volume":"70","author":"Cappi","year":"2012","journal-title":"Arq Neuropsiquiatr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/iji.12147","article-title":"Association of the tumor necrosis factor\u2212308 A\/G promoter polymorphism with Tourette syndrome","volume":"41","author":"Keszler","year":"2014","journal-title":"Int J Immunogenet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00702-017-1732-9","article-title":"The IL-1\u03b2 phenomena in neuroinflammatory diseases","volume":"125","author":"Mendiola","year":"2018","journal-title":"J Neural Transm"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.seizure.2018.04.023","article-title":"Cytokine levels in febrile seizure patients: a systematic review and meta-analysis","volume":"59","author":"Kwon","year":"2018","journal-title":"Seizure."},{"key":"B38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1515\/revneuro-2013-0045","article-title":"Proinflammatory and anti-inflammatory cytokines in febrile seizures and epilepsy: systematic review and meta-analysis","volume":"25","author":"Saghazadeh","year":"2014","journal-title":"Rev Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1503\/jpn.100080","article-title":"Elevation of cerebrospinal fluid interleukin-1\u03b2 in bipolar disorder","volume":"36","author":"S\u00f6derlund","year":"2011","journal-title":"J Psychiatry Neurosci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","article-title":"Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression","volume":"2","author":"Passos","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11920-012-0272-0","article-title":"Systematic review of proinflammatory cytokines in obsessive-compulsive disorder","volume":"14","author":"Gray","year":"2012","journal-title":"Curr Psychiatry Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2190\/PM.46.2.b","article-title":"Association study between IL-1\u03b2-511 C\/T polymorphism and obsessive-compulsive disorder (OCD) in Chinese han population","volume":"46","author":"Bo","year":"2013","journal-title":"Int J Psychiatry Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-015-1402-7","article-title":"The role of IL-17 in CNS diseases","volume":"129","author":"Waisman","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1074\/jbc.M308809200","article-title":"Functional cooperation between interleukin-17 and tumor necrosis factor-\u03b1 is mediated by CCAAT\/Enhancer-binding protein family members*","volume":"279","author":"Ruddy","year":"2004","journal-title":"J Biol Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.4049\/jimmunol.169.10.5897","article-title":"IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts","volume":"169","author":"Maertzdorf","year":"2002","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3233\/JPD-191699","article-title":"Plasma IL-6 and IL-17A Correlate with severity of motor and non-motor symptoms in Parkinson's disease","volume":"9","author":"Green","year":"2019","journal-title":"J Park Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.15412\/J.BCN.03070207","article-title":"Elevated IL-17 and TGF-\u03b2 serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder","volume":"7","author":"Davami","year":"2016","journal-title":"Basic Clin Neurosci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2017.08.001","article-title":"Th17 cells in depression","volume":"69","author":"Beurel","year":"2018","journal-title":"Brain Behav Immun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1742-2094-9-158","article-title":"Elevated serum levels of interleukin-17A in children with autism","volume":"9","author":"AL-Ayadhi","year":"2012","journal-title":"J Neuroinflammation."},{"key":"B50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity."},{"key":"B51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J Neuroinflammation."},{"key":"B52","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-immunol-020711-075041","article-title":"Brain-reactive antibodies and disease","volume":"31","author":"Diamond","year":"2013","journal-title":"Annu Rev Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fimmu.2017.00442","article-title":"Hello from the other side: how autoantibodies circumvent the blood\u2013brain barrier in autoimmune encephalitis","volume":"21","author":"Platt","year":"2017","journal-title":"Front Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.200902153","article-title":"Caveolin-1\u2013dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo","volume":"189","author":"Marchiando","year":"2010","journal-title":"J Cell Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","article-title":"Disruption of central nervous system barriers in multiple sclerosis","volume":"1812","author":"Alvarez","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0004867418796955","article-title":"Leaky brain in neurological and psychiatric disorders: Drivers and consequences","volume":"52","author":"Morris","year":"2018","journal-title":"Aust N Z J Psychiatry."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.893815\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T07:11:11Z","timestamp":1660893071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.893815\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":57,"alternative-id":["10.3389\/fped.2022.893815"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.893815","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"article-number":"893815"}}